Immediate Impact
67 standout
Citing Papers
Role of SLC7A11/xCT in Ovarian Cancer
2024 Standout
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
Works of Allison E. Axtell being referenced
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment
2010
Platinum/taxane‐based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Allison E. Axtell | 590 | 707 | 384 | 13 | 873 | |
| Tom Manolitsas | 773 | 561 | 267 | 27 | 1.0k | |
| R.E. Bristow | 371 | 645 | 449 | 9 | 855 | |
| Stephen Dobbs | 542 | 963 | 639 | 16 | 1.1k | |
| H. Dahan | 668 | 371 | 339 | 24 | 1.2k | |
| Maria Giovanna Salerno | 493 | 425 | 330 | 26 | 830 | |
| Daniel S. Metzinger | 627 | 572 | 332 | 33 | 1.0k | |
| Helena O’Flynn | 454 | 324 | 547 | 23 | 1.1k | |
| F McGlynn | 398 | 353 | 439 | 17 | 881 | |
| G Bratina | 409 | 734 | 280 | 24 | 1.0k | |
| J A Blessing | 718 | 709 | 392 | 17 | 1.1k |
All Works
Loading papers...